Receiver operating characteristics analysis was conducted between the NAFLD versus control, NASH versus control, non-NASH vs. control, and NASH vs. non-NASH groups based on plasma LFABP levels. Here, FABP1 is linked to metabolic dysfunction-associated steatotic liver disease.